Amarin Corporation plc

Contributing Author

Recent Articles by Amarin Corporation plc

Nov-09	New REDUCE-IT Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA/VAZKEPA (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients AMRN GlobeNewswire
Nov-03	Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025 AMRN GlobeNewswire
Oct-29	Amarin Reports Third Quarter 2025 Financial Results AMRN GlobeNewswire
Oct-27	Amarin Issues Statement Supporting FDA's Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit AMRN GlobeNewswire
Oct-15	Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025 AMRN GlobeNewswire
Oct-14	Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT and EPA Mechanistic Data at the Canadian Cardiovascular Congress AMRN GlobeNewswire
Aug-31	Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025 AMRN GlobeNewswire
Aug-30	New REDUCE-IT Analyses Presented at ESC 2025 Include Data Showing VASCEPA/VAZKEPA (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups AMRN GlobeNewswire
Aug-25	New Analyses from REDUCE-IT and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025 AMRN GlobeNewswire
Jul-30	Amarin Reports Second Quarter 2025 Financial Results AMRN GlobeNewswire
Jul-23	Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025 AMRN GlobeNewswire
Jun-24	Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA (Icosapent Ethyl) in Europe AMRN GlobeNewswire
May-07	Amarin Reports First Quarter 2025 Financial Results AMRN GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.